India's position on intellectual property rights and pharmaceutical issues in proposed trade agreements strikes a balance between fostering innovation and addressing public health needs. By resisting pressures from developed nations regarding concepts like 'data exclusivity' and 'patent linkage' in free trade agreements, India facilitates greater market access for generic drug manufacturers, leading to a significant reduction in the cost of …
